Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients
β Scribed by Sester, Martina; Sester, Urban; Clauer, Peter; Heine, Gunnar; Mack, Ulrich; Moll, Thomas; Sybrecht, Gerhard W.; Lalvani, Ajit; Kohler, Hans
- Book ID
- 109065443
- Publisher
- Nature Publishing Group
- Year
- 2004
- Tongue
- English
- Weight
- 198 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0085-2538
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: During screening for latent tuberculosis infection (LTBI), before anti-tumor-necrosis-factor-a treatment, most patients are already receiving immunosuppressive therapy. The objective was to evaluate the performance of the QuantiFERON Gold In-Tube (QFT-IT) and the Tuberculin Skin Test (TS
## Abstract ## Objective To investigate QuantiFERONβtuberculosis Gold (QFTβG) assay and tuberculin skin test (TST) for latent tuberculosis (TB) infection (LTBI) in patients with rheumatoid arthritis (RA) treated with adalimumab. ## Methods We prospectively followed up 43 RA patients who received